Second primary malignancies in cancer survivors: epidemiology, role of anticancer therapy
The recent years have seen considerable advancement in the therapy of oncology patients and hence better survival and longer lifespan. Thus, studies on the distant effects of antitumor therapy have become increasingly important. That particularly concerns the risk of development of the second primar...
Main Author: | L. G. Solenova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2016-09-01
|
Series: | Uspehi Molekulârnoj Onkologii |
Subjects: | |
Online Access: | https://umo.abvpress.ru/jour/article/view/68 |
Similar Items
-
Second primary malignancies of cancer patients: treatment-related carcinogenesis
by: G. A. Belitskiy, et al.
Published: (2016-09-01) -
A systematic review of non-standard dosing of oral anticancer therapies
by: Faouzi Djebbari, et al.
Published: (2018-11-01) -
O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy
by: Wei Yu, et al.
Published: (2020-01-01) -
Selenium Compounds as Novel Potential Anticancer Agents
by: Dominika Radomska, et al.
Published: (2021-01-01) -
Nanohydroxyapatite-Mediated Imatinib Delivery for Specific Anticancer Applications
by: Paulina Sobierajska, et al.
Published: (2020-10-01)